10-K: Sensus Healthcare Reports Strong Revenue Growth and Profitability in 2024

Sensus Healthcare achieved significant revenue growth and profitability in 2024, driven by increased unit sales of its SRT-100 product line.

Summary

• Sensus Healthcare, Inc. reported its financial results for the year ended December 31, 2024, showcasing substantial revenue growth and sustained profitability.
• Revenue increased by 71% to $41.8 million in 2024, compared to $24.4 million in 2023, primarily due to a higher number of units sold.
• The company sold 115 units in 2024, compared to 67 units in 2023.
• Cost of sales increased by 69% to $17.4 million, reflecting the higher unit sales volume.
• Gross profit rose by 73% to $24.4 million, representing 58.4% of revenue, compared to 57.8% in the previous year.
• General and administrative expenses increased by 37% to $7.1 million, driven by higher compensation, professional fees, and bad debt expense.
• Selling and marketing expenses decreased by 11% to $5.0 million due to lower marketing agency expense, travel expense, and payroll cost.
• Research and development expenses increased by 14% to $4.2 million, primarily due to higher compensation expenses and existing product development cost.
• Net income for 2024 was $6.6 million, or $0.41 per share, compared to $0.5 million, or $0.03 per share, in 2023.
• Cash and cash equivalents decreased slightly to $22.1 million at December 31, 2024.
• Accounts receivable increased to $19.7 million, primarily due to increased sales to a major customer with extended payment terms.
• Inventories decreased to $10.1 million due to shipments of units sold during the year.
• The company's revolving credit facility with Comerica Bank was amended in October 2024 to extend the term to November 1, 2026, and increase the maximum borrowings to $15.0 million.
• Management believes that existing financial resources, including the revolving line of credit, are sufficient to meet operating capital and funding requirements for the next 12 months.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong revenue growth and profitability, indicating a favorable sentiment.

Positives

• Significant revenue growth indicates strong market demand for Sensus Healthcare's products.
• Improved profitability demonstrates effective cost management and operational efficiency.
• Increased unit sales reflect successful sales and marketing efforts.
• Amendment of the revolving credit facility provides increased financial flexibility.
• The company remediated a previously disclosed material weakness around information technology general controls.

Negatives

• Increased general and administrative expenses could impact future profitability if not managed effectively.
• Concentration of revenue with a single customer poses a risk to future financial performance.
• Sensus Healthcare is subject to various federal, state, and foreign healthcare laws and regulations, and a finding of failure to comply with these laws and regulations could have a material adverse effect on its business.

Risks

• Dependence on third-party payor coverage and reimbursement for the use of the company's products.
• Concentration of customers in the U.S. and reliance on a single preferred supplier for key components.
• Potential for information technology systems failures, data breaches, or cyberattacks.
• Need for additional funding in the future, which may not be available on acceptable terms.
• Competition from new products, treatments, or technologies that gain wider acceptance.
• Exposure to various federal, state, and foreign healthcare laws and regulations.
• The company is party to certain legal proceedings in the ordinary course of business.

Future Outlook

Sensus Healthcare seeks to maintain and increase profitability in 2025 by increasing sales and managing operational expenses, while continuing to invest in research and development of new products and marketing initiatives.

Management Comments

• Sensus achieved profitability for the first time in 2021, maintained profitability in 2023 and 2024, and seeks to maintain and increase profitability in 2025 by, among other things, increasing sales and managing operational expenses where necessary in order to continue to invest in research and development of new products and marketing initiatives to promote the Company's products.

Industry Context

The medical device industry is highly competitive and subject to rapid technological change, requiring companies like Sensus Healthcare to continuously innovate and adapt to maintain market share.

Comparison to Industry Standards

• The document does not contain specific comparisons to industry standards or comparable companies.
• Without specific benchmarks, it's difficult to assess Sensus Healthcare's performance relative to industry peers like Accuray, Elekta, or Varian Medical Systems in terms of revenue growth, profitability, or market share.
• A more detailed analysis would require comparing Sensus Healthcare's financial metrics to those of similar-sized companies in the radiation therapy device market.

Legal Proceedings

• The Company is party to certain legal proceedings in the ordinary course of business.
• In 2015, the Company learned that the Department of Justice (the Department) had commenced an investigation of the billing to Medicare by a physician who had treated patients with the Company's SRT-100.
• The Department subsequently advised the Company that it was considering expanding the investigation to determine whether the Company had any involvement in physicians use of certain reimbursements codes.

Stakeholder Impact

• Shareholders will benefit from the increased profitability and potential for future growth.
• Employees may benefit from potential compensation increases and career advancement opportunities.
• Customers will benefit from continued access to innovative and effective treatment options.

Next Steps

• The company plans to continue selling and marketing its products to both the dermatology and radiation oncology markets concurrently.
• Management regularly evaluates cash requirements for current operations, commitments, capital requirements, and business development transactions, and may seek to raise additional funds for these purposes in the future.

Key Dates